Introduction
Red blood cells represent one of the most abundant specialized cell types in vertebrate organisms. They develop from bone marrow stem cells through successive stages of differentiation including progenitors that are already committed to the erythroid lineage referred to as burst forming unit erythroid (BFU-E) and colony forming unit erythroid (CFU-E). Proliferation of erythroid progenitor cells and their differentiation into fully mature red cells are controlled by different sets of transcription factors such as the cMyb proto-oncoprotein, GATA-1 and GATA-2, erythroid kruppel-like factor (EKLF), the leucine zipper protein NF-E2 and the helix-loop-helix transcription factor Tal-1/SCL and the LIM domain containing factor LMO2/Rbtn2 (Ness and Engel, 1994; Graf, 2002) . Another important family of transcriptional regulators involved in erythropoiesis includes nuclear receptors such as the thyroid hormone receptor TRa, the retinoic acid receptors RAR and RXR, and the steroid hormone receptors estrogen receptor and glucocorticoid receptor (ER and GR) respectively; Wessely et al., 1997; Bartunek and Zenke, 1998; Bauer et al., 1998; von Lindern et al., 1999; and references therein) .
GATA-1, the first major erythroid lineage specific transcription factor identified, represents one of the major regulators of erythroid cell development as demonstrated by gene inactivation and rescue experiments in vivo and in vitro (Evans and Felsenfeld, 1989; Tsai et al., 1989; Pevny et al., 1991; Simon et al., 1992) . GATA-1 protein binds to the consensus DNA motif WGATAR that is contained in virtually all erythroid specific genes (Weiss and Orkin, 1995) . During erythroid cell differentiation GATA-1 is post-translationally regulated: in immature progenitors GATA-1 protein is confined to the cytoplasm, while induction of differentiation causes GATA-1 to translocate into the nucleus (Briegel et al., 1996) . Additionally, GATA-1 protein becomes post-translationally modified by phosphorylation in response to external signals and by acetylation (Crossley and Orkin, 1994; Boyes et al., 1998) . Finally, GATA-1 activity requires association with Friend of GATA-1 (FOG-1; Tsang et al., 1997) , and gene inactivation of FOG-1 in mice generates a phenotype that is similar to that observed for GATA-1 null mice although more pronounced in megakaryocytes (Tsang et al., 1998) .
Erythroid progenitors abundantly express the protooncogene c-myb, and gene inactivation of c-myb in mice leads to embryonic lethality because of the absence of adult erythropoiesis, while the development of the fetal erythroid compartment is not compromised (Mucenski et al., 1991) . These findings unequivocally demonstrate that both GATA-1 and c-myb are absolutely required for development of red blood cells.
During the onset of differentiation c-myb expression is downregulated in various hematopoietic cell types, and downregulation of c-myb appears to be required for their terminal differentiation (Cuddihy et al., 1993; Lyon and Watson, 1995) . Specific factors have been implicated in direct regulation of c-myb transcription such as E2F, various Ets and AP-1 family members, MZF1, WT1 and the respective binding sites have been identified within the c-myb promoter (Nicolaides et al., 1992; McCann et al., 1995; Perrotti et al., 1995; Bellon et al., 1997; Sullivan et al., 1997; Campanero et al., 1999) . Yet, the factors that are responsible for c-myb downregulation during erythroid cell differentiation have remained elusive.
In the past several years in vitro culture systems have been developed that faithfully recapitulate red blood cell development in vitro employing various types of hematopoietic progenitor cells and culture conditions (Fibach et al., 1991; Dolznig et al., 1995 Dolznig et al., , 2001 Dolznig et al., , 2002 Wessely et al., 1997; Bartunek and Zenke, 1998; Panzenbock et al., 1998; von Lindern et al., 1999; Zhang et al., 2001; Bartunek et al., 2002) . Such in vitro differentiation systems have allowed the study of the molecular mechanisms that underlie the erythroid cell differentiation program. Erythroid progenitor cells can be isolated for example from human, mouse and chicken bone marrow and amplified in vitro in the presence of cytokines and steroid hormones as homogenous cell populations to large cell numbers. Additionally, cells can be induced to effectively undergo normal terminal differentiation in the presence of specific differentiation factors, like erythropoietin and insulin, and yield fully mature red cells. Since well-defined experimental conditions are employed, such in vitro systems are particularly well suited to study the molecular events ongoing when cells differentiate.
Using stem cell factor (SCF)-dependent erythroid progenitor cells (in the following referred to as SCF progenitors) we have now investigated the direct interaction of the GATA-1 protein with the c-myb locus and have identified GATA-1 binding sites in the c-myb promoter. We demonstrate that GATA-1 negatively regulates c-myb promoter activity and this requires FOG-1.
Results
c-myb and GATA-1 expression during red blood cell differentiation SCF progenitors were generated from bone marrow and induced to differentiate in vitro. RNA was isolated after various periods of time and subjected to Northern blot analysis. It was found that SCF progenitors expressed high levels of c-myb proto-oncogene mRNA that remained unchanged for 16 h after differentiation induction (Figure 1) . At 20 h of differentiation c-myb expression started to decline and c-myb mRNA was barely detectable at the late stages of differentiation when terminally differentiated cells accumulated (72 and 96 h). Conversely, GATA-1 mRNA was low in progenitor cells and accumulated during differentiation starting at 8 h and reaching maximal levels at 16 h (Figure 1 ). In terminally differentiated cells GATA-1 expression was low because of shut down of overall production of RNA.
GATA-1 protein expression followed similar kinetics as GATA-1 mRNA starting at 8 h of differentiation (Figure 2a) . Additionally, in accord with our previous studies, GATA-1 protein in SCF progenitors was cytoplasmic, while in differentiating cells GATA-1 Figure 1 c-myb and GATA-1 expression during red cell differentiation. Northern blot analysis of RNA from SCF progenitors at various time points of differentiation as indicated. Blots were hybridized with c-myb and GATA-1 probes, respectively. 28S RNA stained with methylene blue is shown to demonstrate equal RNA loading Figure 2 GATA-1 protein expression and DNA-binding activity during red blood cell differentiation. (a) Western blot analysis with GATA-1 specific antibody of total cell lysates (total) from differentiating SCF progenitors (same samples as in Figure 1 ) and from cytoplasmic (cyto) or nuclear (nuclear) extracts after cell fractionation. (b) EMSA with nuclear extracts (same as in a) using 32 P-labelled MaP and HS77 (À1040 GATA-1 binding site) oligonucleotide probes as indicated. Only DNA-protein complexes are shown GATA-1 and c-myb crosstalk in erythroid differentiation P Bartůněk et al protein was increasingly abundant in the nuclear fraction from 20 h onwards ( Figure 2a and Briegel et al., 1996) . Furthermore, multiple GATA-1 bands were observed, which most likely represent different phosphorylated GATA-1 isoforms (Crossley and Orkin, 1994; Briegel et al., 1996) . The GATA-1 protein effectively bound to MaP oligonucleotide containing a GATA consensus site of the mouse a1-globin promoter (Tsai et al., 1989; Briegel et al., 1996) already 2 h after the induction of differentiation. Interestingly, the binding affinity of GATA-1 protein to HS77 oligonucleotide containing the À1040 GATA site of the chicken c-myb promoter (see below) started at 4 h, remained low to moderate until 16 h of differentiation, and then increased thereby following nuclear GATA-1 protein levels ( Figure 2b ).
Identification of GATA-1 binding sites in the c-myb promoter
The efficient downregulation of c-myb transcription concomitantly with GATA-1 upregulation suggested to us that GATA-1 might be directly involved in the regulation of the c-myb proto-oncogene. Such an idea would also be in line with our previous observation that c-myb upstream sequences bind erythroid specific factors (P Bartunek, M Dvorak and M Zenke, unpublished results). Furthermore, GATA-1 protein represents one of the major regulators in erythroid cells and downregulation of c-myb expression was suggested to be required for effective differentiation of red blood cells (Cuddihy et al., 1993; Lyon and Watson, 1995) . Therefore we set up experiments to identify GATA-1 binding sites in the c-myb promoter by employing multiple band shift assay (Kozmik and Paces, 1990) . The 1.4 kb c-myb promoter fragment ( Figure 3a ) was digested with HaeIII and SacII, respectively, incubated with recombinant GATA-1 protein and subjected to multiple band shift assay. In this assay the disappearance of bands with increasing GATA-1 concentrations is indicative for protein binding to the respective DNA fragment(s). This analysis identified two fragments of 240 and 307 bp in the HaeIII digest and two fragments of 124 and 477 bp in the SacII digest that bound GATA-1 protein ( Figure 3b ). Interestingly, the 240 and 124 bp fragments comprise the same DNA element, while the 307 and 477 bp fragments comprise yet a second DNA element (see below). Inspection of the nucleotide sequence of the 307 bp HaeIII fragment revealed a potential GATA-1 binding site at position À1040 (in the following referred to as À1040 GATA-1 binding site; Figures 3a and 4a ). This finding is in accord with our previous observation that this c-myb promoter fragment binds an erythroid specific factor (P Bartunek, M Dvorak and M Zenke, unpublished results). Interestingly, the À1040 GATA-1 site overlaps with one of three myb binding sites (MBS) that were identified before (Figures 3a and 4a ; Dvorak et al., 1989) .
The 124 bp SacII fragment comprises c-myb promoter sequences that are highly conserved among various vertebrate species therefore referred to as evolutionary conserved (EC) element (Urbanek et al., 1988) . Inspection of the EC nucleotide sequence identified a potential GATA-1 binding site located at position +1 with respect to cap site region I (CSR I, Dvorak et al., 1989) and corresponding to position À30 with respect to cmyb cap site region II (CSR II; Figure 5a ). This sequence element is in the following referred to as (À30/+1) GATA-1 binding site.
GATA-1 binding to À1040 and À30/+1 of the c-myb promoter
To demonstrate directly GATA-1 binding to the À1040 GATA-1 binding site, a HpaII-SmaI fragment comprising this site (in the following referred to as HS77) was subjected to EMSA analysis (Figure 4a and b). As Increasing amounts of GST-GATA-1 protein were added as indicated (see also Materials and methods) and fragments were resolved in polyacrylamide gels. Fragments that bind GATA-1 with high affinity are depicted (arrows) and their size is indicated GATA-1 and c-myb crosstalk in erythroid differentiation P Bartůněk et al expected GATA-1 protein present in extracts of SCF progenitors was effectively bound to HS77 fragment, and complex formation was competed with MaP oligonucleotide harboring a functional GATA-1 site but not with an oligonucleotide containing a mutated GATA-1 site (mMaP), or a myb binding site. Additionally, GATA-1 specific antibodies abolished GATA-1 binding, while GATA-2 and GATA-3, and Myb specific antibodies did not. Note that with the conditions employed there is no c-myb binding to the HS77 fragment, since the extracts used were prepared according to standard methods (Dignam et al., 1983 ) that do not contain c-myb protein (P Bartunek, M Dvorak and M Zenke, unpublished results). We emphasize, however, that the À1040 GATA-1 site can bind both c-Myb and v-Myb proteins (see below).
GATA-1 binding to the À1040 GATA-1 binding site is intriguing since this site overlaps with a cluster of myb binding sites (MBS; Figures 3a and 4a) suggesting that mutually exclusive binding of these protein factors might occur. Additionally, GATA-1 binding to the À1040 binding site was moderate to low during the initial phase of differentiation but effectively increased after 20 h and thus correlated with c-myb downregulation (Figures 1b and 2b) . EMSA with HS77 probe, and oligonucleotide competition and antibody supershift experiments (polyclonal anti-GATA-1 #180) with nuclear extracts from SCF progenitors. MaP, mMaP and MYB, wild-type MaP, mutated MaP and MYB oligonucleotides, respectively, used in oligocompetition experiments. a-GATA-1, a-GATA-2, a-GATA-3 and a-MYB, GATA-1, GATA-2, GATA-3 and Myb specific antisera, respectively, employed in supershifts Urbanek et al., 1988) containing GATA/TATA-like element, and CSRI and CSRII, respectively (Dvorak et al., 1989) . E2F, PEA3 and Sp1 binding sites, and SacII endonuclease cleavage sites are indicated. Transcriptional start sites, filled triangles. (b) EMSA using 124 bp long SacII fragment of the EC element and nuclear extracts from chicken HD3 erythroleukemia cells (ch) and mouse MEL erythroleukemia cells (mu). Arrows indicate chicken (ch) and mouse (m) DNA-GATA-1 complex, respectively. Vertical bar indicates multiple complexes binding to EC element (e.g. to E2F and Sp1 sites). MaP and Sp1, competition with MaP and Sp1 oligonucleotide, respectively; a-GATA-1, addition of pan-anti-GATA-1 antibody #H2 (a-GATA-1). (c) ZOO band shift with nuclear extracts from chicken (ch), mouse (mu) and human (hu) erythroleukemia cell lines (HD3, MEL and K562), respectively, and chicken CSR I oligonucleotide as a probe. Bandshift reactions were done in the absence (À) or presence (+) of polyclonal pananti-GATA-1 antibody #H2 (a-GATA-1) to supershift DNA-GATA-1 complexes. Arrows indicate GATA complexes, star depicts the migration of ternary DNA-protein-antibody complexes and bracket indicates non-specific binding GATA-1 and c-myb crosstalk in erythroid differentiation P Bartůněk et al GATA-1 also bound to the À30/+1 GATA-1 binding site in EC as demonstrated by EMSA (Figure 5 a-c) . Addition of an oligonucleotide bearing a consensus GATA site (MaP) effectively competed for binding while an oligonucleotide with a mutated GATA-1 or Sp1 site did not (Figure 5b and data not shown) . Furthermore GATA-1 specific antibody supershifted the DNA-protein complex. Interestingly, the addition of Sp1 oligonucleotide diminished the high molecular weight complexes bound to EC element and enhanced the GATA-1 specific band. This was observed both for chicken and mouse GATA-1 proteins present in HD3 and MEL nuclear extracts, respectively (Figure 5b ).
The EC region was then scanned with a panel of oligonucleotides for GATA-1 binding and only the oligonucleotide bearing the À30/+1 GATA-1 site efficiently bound GATA-1 protein (Figure 5c and data not shown; see Materials and methods for chCSR I). GATA-1 binding to the À30/+1 GATA-1 site is interesting since this GATA-1 site overlaps with the cap site CSR I or the À30 position of CSR II. It is demonstrated here that chicken, mouse and human GATA-1 bind to this element and that DNA-GATA-1 protein complexes are supershifted with GATA-1 specific antibody (Figure 5c ). Additionally, an oligonucleotide corresponding to the respective human sequence element also bound chicken, mouse, human and even Xenopus GATA-1, albeit with somewhat different preferences (data not shown).
GATA-1 regulates c-myb promoter activity in vivo
To determine whether the À1040 and À30/+1 GATA-1 sites are active in vivo, transient cotransfection experiments were performed. A reporter plasmid with elevated basal luciferase expression (pTL109; Nordeen, 1988) was selected and À1040 or À30/+1 GATA-1 sites were cloned upstream of the HSV-TK promoter that drives luciferase expression. GATA-1 and FOG-1 expression vector were cotransfected, both individually and simultaneously. Repression of reporter gene activity via the À1040 GATA-1 binding site required both GATA-1 and FOG-1, while GATA-1 or FOG-1 alone were inactive (Figure 6a ). Additionally, there was no repression by a mutated À1040 GATA-1 site as expected. To further extend these observations, a reporter plasmid pLucbTATA with low basal activity was used (Bartunek et al., 1997) . In this vector the composite À1040 GATA-1/Myb binding site was activated by c-Myb by fivefold (Figure 6b) . Transfection of GATA-1 resulted in only a marginal increase of reporter activity while there was no effect by FOG-1. Transfection of c-Myb and increasing amounts of GATA-1 enhanced reporter activity to levels higher than seen for c-Myb alone. Importantly however, in the presence of FOG-1 increasing amounts of GATA-1 repressed reporter activity close to basal levels ( Figure 6b ).
Transfection experiments with the À30/+1 GATA-1 luciferase reporter and the respective mutated GATA-1 site gave luciferase values similar to empty vector control (data not shown). So far the analysis of the À1040 and À30/+1 GATA-1 binding sites within the context of the bona fide c-myb promoter was not possible since reporter constructs containing even several kilobases of c-myb upstream sequence were essentially inactive employing a variety of different cell types Finally, since c-myb repression by GATA-1 required FOG-1 and the GATA-l/FOG-1 cooperation was demonstrated in several systems (Tsang et al., 1997 (Tsang et al., , 1998 , we analysed the pattern of FOG-1 expression during terminal red cell differentiation. SCF progenitors were prepared and induced to differentiate, RNA was isolated after various periods of time and analysed for FOG-1 expression by Northern blotting. It was found that erythroid progenitors express 4.0 kb FOG-1 mRNA which is further increased during differentiation (Figure 6b ).
Discussion
GATA-1 and c-Myb transcription factors represent key regulators of red cell development as demonstrated by gene inactivation experiments in mice (Mucenski et al., 1991; Pevny et al., 1995) . Here we followed the kinetics of GATA-1 and c-myb proto-oncogene expression during red cell differentiation by employing a culture system that recapitulates red cell development in vitro. We show that GATA-1 is effectively upregulated during differentiation and nuclear GATA-1 protein starts to accumulate at 20 h postdifferentiation induction, and at the same time c-myb expression is downregulated. Additionally, we have identified two GATA-1 binding sites within the c-myb promoter and demonstrate that GATA-1 protein binds to these sites in vitro. Furthermore, GATA-1 represses c-myb expression through the À1040 GATA-1 binding site in transient cotransfection experiments and this requires FOG-1.
The more distal GATA-1 binding site identified in this study is located at position À1040 with respect to the cmyb transcriptional start site. Interestingly, this GATA site overlaps with a cluster of three Myb binding sites that are also present in an analogous position in the human c-myb promoter. These Myb sites were shown before to bind c-Myb protein and mediate transactivation of the c-myb promoter by c-Myb (Nicolaides et al., 1991) . Importantly, as demonstrated here increasing amounts of GATA-1 repressed gene expression via this À1040 GATA-1 site in transient cotransfection experiments and this required FOG-1. Thus, GATA-1/FOG-1 and Myb might bind to these overlapping sequence elements in a mutual exclusive fashion. This idea is also supported by in vitro binding studies demonstrating that GATA-1 and c-Myb proteins effectively competed for binding to the À1040 site in EMSA (data not shown). Therefore, a model presents itself where Myb induces c-myb transcription via this composite À1040 GATA-1/Myb binding site, while increasing amounts of GATA-1 downregulate c-myb expression through the very same sequence element and this requires FOG-1. In support of this model GATA-1 binding to the À1040 GATA-1 binding site was low from 2 to 16 h of differentiation, but effectively increased after 20 h and thus correlated with c-myb downregulation (Figures 1 and 2b) . GATA-1 binding to the À1040 site in vitro was more selective than binding to the MaP element of the mouse al-globin promoter, which might be because of the sequence context of the À1040 site and/or specific post-translational modifications of the GATA-1 protein such as phosphorylation.
The second more proximal À30/+1 GATA-1 binding site is contained in a sequence that is highly conserved between different organisms, referred to as EC element (Urbanek et al., 1988) . In addition, this GATA-1 site overlaps with the upstream transcriptional start site (CSR I) which most interestingly also represents the À30 position of the downstream transcriptional start site (CSR II). Here we show that GATA-1 protein binding to CSR I is evolutionary conserved from Xenopus to man. GATA-1 did however not repress expression of reporter genes via this À30/+1 GATA-1 site in transient cotransfection assays. This was observed irrespective of the presence or absence of FOG-1 and the reasons for this are not clear but might be because of inherent limitations in this type of assay. In this context we note that similar to the c-myb gene, a number of known GATA-1 target genes have a GATA site at position À30, including genes for platelet factor 4 (PF4), erythropoietin and b-globin (Chiba et al., 1991; Fong and Emerson, 1992; Aird et al., 1994) . The model proposed for the regulation of PF4 gene in megakaryopoiesis was that GATA proteins compete with TFIID for core promoter binding (Aird et al., 1994) . Thus, it is very well possible that GATA-1 and factors of the basal transcription machinery compete for binding to the very same sequence element. This might be particularly relevant late in red cell differentiation when GATA-1 protein becomes very abundant and c-myb transcription is downregulated. Such a mechanism is further supported by our initial experiments with TATA-binding protein (TBP) showing that His-huTBP binds to CSR I in vitro (data not shown).
All this is in line with the observation that during terminal differentiation of red cells, c-myb transcription is downregulated concomitantly with the upregulation of GATA-1 expression. Thus, increased GATA-1 level might well be the trigger that causes downregulation of c-myb transcription. This idea is also supported by experiments on in vitro differentiation of GATA-1 À ES cells. GATA-1 À erythroid cells show higher levels of c-myb expression than erythroid cells derived from wildtype ES cells (Weiss et al., 1994) suggesting that GATA-1 is important for c-myb downregulation in vivo. Furthermore, in previous work we demonstrated that the hormone inducible GATA-1 estrogen receptor fusion GATA-1/ER caused c-myb downregulation in response to estrogen (Briegel et al., 1996) . The present study extends these findings in that GATA-1 protein (and probably also GATA-1/ER protein) directly interact with c-myb promoter sequences.
GATA-1 action requires association with the cofactor FOG-1 (Tsang et al., 1997 (Tsang et al., , 1998 . Accordingly, GATA-1 and FOG-1 synergize both in transient transactivation assays and in inducing terminal erythroid differentiation of G1E cells (Tsang et al., 1997) . Here we show that FOG-1 increases when progenitor cells differentiate into mature red cells. Furthermore, in Xenopus FOG was shown to act as a repressor of red cell development in vivo, which led to the hypothesis that in addition to its coactivator function FOG might act as a corepressor for some GATA target genes, such as GATA-2 (Deconinck et al., 2000) . This mode of action would be in line with the results reported here that FOG is required for the repression of c-myb transcription. Additionally, both GATA-2 and c-myb have an important function in proliferating erythroid progenitor cells and their downregulation is required for terminal differentiation (Briegel et al., 1993; Cuddihy et al., 1993; Lyon and Watson, 1995) .
In summary, while previous studies demonstrated the impact of GATA-1 and Myb for red cell development, this work extends these findings and provides evidence for a direct molecular link between these transcription factors. In addition, GATA-1 and c-myb appear to be important both for establishing the red cell lineage and for orchestrating the terminal red cell differentiation program.
Materials and methods

Plasmids and oligonucleotides
Luciferase reporters contain HX45 or mHX45 oligonucleotides (see below) harboring the wildtype À1040 GATA-1 binding site or a mutated GATA-1 binding site, respectively, between HindIII and XhoI of pTL109 vector (Nordeen, 1988) . pLuc bTATA is a derivative of pGLBasic and contains a rabbit b-globin TATA sequence element upstream of the luciferase gene. Chicken GATA-1 was expressed from TFAneo (Yamamoto et al., 1990) and chicken c-myb from pNeo-CCd vector (Grasser et al., 1991) . Human FOG-1 cDNA (Tsang et al., 1997) was cloned into pcDNAl and used in transient transfection assays. Chicken 0.29 kb FOG-1 specific probe was obtained by RT-PCR from SCF progenitors using specific primers FOG-1 and FOG-2 (5 0 -CCAGGGCAGCATCCA-CAGTG-3 0 and 5 0 -CGGGTAGGGCGAGTCTCCAG-3 0 , respectively) that were designed based on chicken EST Gen Bank Accession number BG710230, and the FOG-1 specific fragment was subcloned in pCR2.1 (Invitrogen).
In EMSA the following oligonucleotides were used (Tsai et al., 1989; Briegel et al., 1993 Briegel et al., , 1996 P Bartunek, M Dvorak and M Zenke, unpublished SCF progenitors were generated by cultivating bone marrow cells from 3 to 7-day-old SPAFAS chicks in modified CFU-E medium supplemented with 100 ng/ml of recombinant avian stem cell factor (SCF; Bartunek et al., 1996; Bartunek and Zenke, 1998) . Homogeneous cell populations were obtained after 3-4 days (Dolznig et al., 1995; Bartunek and Zenke, 1998) . To induce erythroid differentiation, cultures of SCF progenitors were incubated in CFU-E medium without chicken serum (referred to as differentiation medium; Zenke et al., 1990; Beug et al., 1995) supplemented with 3% anemic chicken serum (as a source for erythropoietin) plus 100 ng/ml insulin (Novo Nordisk). Effective erythroid differentiation was monitored by assessing hemoglobinization of cells in cytospin preparations with neutral benzidine staining and by measuring [ 3 H]thymidine incorporation and hemoglobin accumulation Dolznig et al., 1995; Bartunek et al., 2002) . Cell numbers and cell size were determined by employing the CASY-1 Cell Counter and Analyzer System (Scha¨rfe System, Reutlingen, Germany).
Cell fractionation
SCF progenitors, prior to and at various time points post induction of differentiation, were harvested, washed with PBS and fractionated as described (Briegel et al., 1996) . Briefly, 1 Â l0 7 cells were lysed in 1 ml lysis buffer (50 mm Tris-HCl pH 7.5, 1 mm MgCl 2 , 0.5% Triton X-100, 10 mm DTT, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mm PMSF) for 10 min on ice. Cytoplasmic and nuclear fractions were separated by centrifugation and cytoplasmic supernatants were recovered. Nuclei were resuspended in 0.2 m NaCl, 30 mm Tris-HCl pH 7.5, 5 mm MgCl 2 , 10% glycerol and protease inhibitors as above, and proteins were extracted by adjusting NaCl to 0.4 m final concentration (20 min on ice), and both cytoplasmic and nuclear extracts were used for Western blot analysis and electrophoretic mobility shift assays.
Northern blot analysis
RNA was isolated from SCF progenitors and analysed by Northern blotting as described (Briegel et al., 1996; Bartunek and Zenke, 1998) . Probes were full-length cDNA of chicken GATA-1 (Yamamoto et al., 1990) , EcoRI-XbaI fragment of v-myb (Bartunek et al., 1992 ) and a 290 bp chicken FOG-1 fragment. Blots were hybridized and washed at moderate stringency and exposed to film.
Western blot analysis
Total, cytoplasmic and nuclear extracts from SCF progenitors were separated on 10% SDS-PAGE gels and blotted onto nitrocellulose membranes (BA85, Schleicher & Schuell). Membranes were blocked overnight in TBS and reacted with polyclonal GATA-1 specific anti-peptide antibody #180 (Briegel et al., 1993 (Briegel et al., , 1996 or pan-GATA-1 #H2 polyclonal antibody (a gift from R. H. Nicolas, Institute Cancer Research, London, UK) in TBS supplemented with 5% nonfat milk powder for 1 h. Subsequently, blots were washed and reacted with the respective secondary antibodies (ECL kit, Amersham Pharmacia Biotech) in TBS supplemented with 5% non fat milk powder (45 min), developed in ECL reagents and exposed to film.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed using 32 P-radiolabelled oligonucleotides or DNA restriction fragments in the absence or presence of 200-fold excess of unlabelled oligonucleotide (30 min on ice). For supershifts, 0.5 ml of polyclonal GATA-1 antibody #180 or #H2 was added to the reactions after 10 min of preincubation. Protein-DNA complexes were resolved on a 5% nondenaturing polyacrylamide gel in 0.25 Â TBE buffer and exposed to film (Briegel et al., 1996) .
Multiple band shift assay
The 1.4 kb BstEII-NotI fragment of chicken c-myb promoter (Dvorak et al., 1989) was digested with HaeIII or SacII restriction enzymes and end-labelled with [a 32 P]dCTP by Klenow DNA polymerase. Increasing amounts of recombinant GST-GATA-1 fusion protein (Ko and Engel, 1993) was added to EMSA reactions and protein-DNA complexes were resolved on 5% nondenaturing polyacrylamide gels (Kozmik and Paces, 1990) .
Cotransfection transactivation assay
Chicken embryo fibroblasts (CEF; 0.6 Â l0 6 cells) or QT6 cells were seeded onto a 60 mm Petri dish in DMEM medium, 5% fetal calf serum, 2% chicken serum, 20 mm HEPES pH 7.5 and transfected with 5 mg of DNA (1 mg of pNeo-CCd, 0.5-1 mg of GATA-1 TFAneo and/or pcDNA-FOG-1 expression vector plus 1 mg of pTL109 or pLucbTATA based luciferase reporter vector, 0.5 mg of pRSV-bGal, and 2.5 mg of pBluescript carrier DNA) using calcium phosphate transfection (Disela et al., 1991; Briegel et al., 1993) . After 16 h cells were rinsed and incubated with fresh growth medium. At day 2 after transfection cells were harvested and cell extracts were prepared and analysed for luciferase activity and normalized for b-galactosidase expression and/or protein concentration (Disela et al., 1991) .
